Allojenik Kemik İliği Nakli İle Tedavi Edilen Langerhans Hücreli Histiyositoz Olgusu

Özet

Langerhans hücreli histiyositoz (LHH), myeloid kökenli malign histiyositik bir hastalıktır. Morfolojik olarak benzedikleri epidermal langerhans hücrelerinden farklıdır. Neoplastik histiyositik hastalıklar içinde en sık görüleni langerhans hücreli histiyositozdur. LHH en sık kemikleri ve cildi etkiler. Ancak kemik iliği, karaciğer, dalak, akciğerler, merkezi sinir sistemi (MSS), hipofiz bezini ve diğer organları da tutabilir. 51 yaşında kadın hasta büyüyen lenf nodları, ateş, gece terlemesi şikayetleri ile başvurdu. Hastanın yapılan lenf nodu eksizyonel biyopsisi LHH olarak geldi. Çeşitli kemoterapiler sonrası %100 uyumlu kardeş vericisinden yapılan allojenik kemik iliği nakli ile tedavi edildi. Hastanın tanısından 10 yıl önce diyabetes insipitus hastalığı teşhisi olup LHH’nin tutulumu olarak düşünüldü. Allojenik nakil tedavisi ile hastanın desmopressin ihtiyacı da geriledi.

Referanslar

Emile JF, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J, vd. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 02 Haziran 2016;127(22):2672-81.

Su M, Gao YJ, Pan C, Chen J, Tang JY. Outcome of children with Langerhans cell histiocytosis and single-system involvement: A retrospective study at a single center in Shanghai, China. Pediatr Hematol Oncol. 2018;35(7-8):385-92.

Astigarraga I, García-Obregón S, Pérez-Martínez A, Gutiérrez-Carrasco I, Santa-María V, Iturrate CRV, vd. Langerhans cell histiocytosis. Advances in pathogenesis and clinical practice. An Pediatr (Engl Ed). Ağustos 2022;97(2):130.e1-130.e7.

Abla O, Jacobsen E, Picarsic J, Krenova Z, Jaffe R, Emile JF, vd. Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease. Blood. 28 Haziran 2018;131(26):2877-90.

Yeh EA, Greenberg J, Abla O, Longoni G, Diamond E, Hermiston M, vd. Evaluation and treatment of Langerhans cell histiocytosis patients with central nervous system abnormalities: Current views and new vistas. Pediatr Blood Cancer. Ocak 2018;65(1).

Prosch H, Grois N, Prayer D, Waldhauser F, Steiner M, Minkov M, vd. Central diabetes insipidus as presenting symptom of Langerhans cell histiocytosis. Pediatr Blood Cancer. Ekim 2004;43(5):594-9.

Hazim AZ, Ruan GJ, Hu M, Ravindran A, Rech KL, Young JR, vd. Langerhans cell histiocytosis with lung involvement in isolation and multisystem disease: Staging, natural history, and comparative survival. Am J Hematol. 01 Aralık 2021;96(12):1604-10.

Emile JF, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J, vd. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 02 Haziran 2016;127(22):2672-81.

Haroche J, Charlotte F, Arnaud L, von Deimling A, Hélias-Rodzewicz Z, Hervier B, vd. High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses. Blood. 27 Eylül 2012;120(13):2700-3.

Aricò M, Girschikofsky M, Généreau T, Klersy C, McClain K, Grois N, vd. Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society. Eur J Cancer. Kasım 2003;39(16):2341-8.

Götz G, Fichter J. Langerhans’-cell histiocytosis in 58 adults. Eur J Med Res. 29 Kasım 2004;9(11):510-4.

Hazim AZ, Ruan GJ, Hu M, Ravindran A, Rech KL, Young JR, vd. Langerhans cell histiocytosis with lung involvement in isolation and multisystem disease: Staging, natural history, and comparative survival. Am J Hematol. 01 Aralık 2021;96(12):1604-10.

Maghnie M, Bossi G, Klersy C, Cosi G, Genovese E, Aricò M. Dynamic endocrine testing and magnetic resonance imaging in the long-term follow-up of childhood langerhans cell histiocytosis. J Clin Endocrinol Metab. Eylül 1998;83(9):3089-94.

Kaltsas GA, Powles TB, Evanson J, Plowman PN, Drinkwater JE, Jenkins PJ, vd. Hypothalamo-pituitary abnormalities in adult patients with langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment. J Clin Endocrinol Metab. Nisan 2000;85(4):1370-6.

McClain KL, Picarsic J, Chakraborty R, Zinn D, Lin H, Abhyankar H, vd. CNS Langerhans cell histiocytosis: Common hematopoietic origin for LCH-associated neurodegeneration and mass lesions. Cancer. 15 Haziran 2018;124(12):2607-20.

Berres ML, Allen CE, Merad M. Pathological consequence of misguided dendritic cell differentiation in histiocytic diseases. Adv Immunol. 2013;120:127-61.

Allen CE, Ladisch S, McClain KL. How I treat Langerhans cell histiocytosis. Blood. 02 Temmuz 2015;126(1):26-35.

Referanslar

Emile JF, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J, vd. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 02 Haziran 2016;127(22):2672-81.

Su M, Gao YJ, Pan C, Chen J, Tang JY. Outcome of children with Langerhans cell histiocytosis and single-system involvement: A retrospective study at a single center in Shanghai, China. Pediatr Hematol Oncol. 2018;35(7-8):385-92.

Astigarraga I, García-Obregón S, Pérez-Martínez A, Gutiérrez-Carrasco I, Santa-María V, Iturrate CRV, vd. Langerhans cell histiocytosis. Advances in pathogenesis and clinical practice. An Pediatr (Engl Ed). Ağustos 2022;97(2):130.e1-130.e7.

Abla O, Jacobsen E, Picarsic J, Krenova Z, Jaffe R, Emile JF, vd. Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease. Blood. 28 Haziran 2018;131(26):2877-90.

Yeh EA, Greenberg J, Abla O, Longoni G, Diamond E, Hermiston M, vd. Evaluation and treatment of Langerhans cell histiocytosis patients with central nervous system abnormalities: Current views and new vistas. Pediatr Blood Cancer. Ocak 2018;65(1).

Prosch H, Grois N, Prayer D, Waldhauser F, Steiner M, Minkov M, vd. Central diabetes insipidus as presenting symptom of Langerhans cell histiocytosis. Pediatr Blood Cancer. Ekim 2004;43(5):594-9.

Hazim AZ, Ruan GJ, Hu M, Ravindran A, Rech KL, Young JR, vd. Langerhans cell histiocytosis with lung involvement in isolation and multisystem disease: Staging, natural history, and comparative survival. Am J Hematol. 01 Aralık 2021;96(12):1604-10.

Emile JF, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J, vd. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 02 Haziran 2016;127(22):2672-81.

Haroche J, Charlotte F, Arnaud L, von Deimling A, Hélias-Rodzewicz Z, Hervier B, vd. High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses. Blood. 27 Eylül 2012;120(13):2700-3.

Aricò M, Girschikofsky M, Généreau T, Klersy C, McClain K, Grois N, vd. Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society. Eur J Cancer. Kasım 2003;39(16):2341-8.

Götz G, Fichter J. Langerhans’-cell histiocytosis in 58 adults. Eur J Med Res. 29 Kasım 2004;9(11):510-4.

Hazim AZ, Ruan GJ, Hu M, Ravindran A, Rech KL, Young JR, vd. Langerhans cell histiocytosis with lung involvement in isolation and multisystem disease: Staging, natural history, and comparative survival. Am J Hematol. 01 Aralık 2021;96(12):1604-10.

Maghnie M, Bossi G, Klersy C, Cosi G, Genovese E, Aricò M. Dynamic endocrine testing and magnetic resonance imaging in the long-term follow-up of childhood langerhans cell histiocytosis. J Clin Endocrinol Metab. Eylül 1998;83(9):3089-94.

Kaltsas GA, Powles TB, Evanson J, Plowman PN, Drinkwater JE, Jenkins PJ, vd. Hypothalamo-pituitary abnormalities in adult patients with langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment. J Clin Endocrinol Metab. Nisan 2000;85(4):1370-6.

McClain KL, Picarsic J, Chakraborty R, Zinn D, Lin H, Abhyankar H, vd. CNS Langerhans cell histiocytosis: Common hematopoietic origin for LCH-associated neurodegeneration and mass lesions. Cancer. 15 Haziran 2018;124(12):2607-20.

Berres ML, Allen CE, Merad M. Pathological consequence of misguided dendritic cell differentiation in histiocytic diseases. Adv Immunol. 2013;120:127-61.

Allen CE, Ladisch S, McClain KL. How I treat Langerhans cell histiocytosis. Blood. 02 Temmuz 2015;126(1):26-35.

Sayfalar

15-20

Gelecek

11 Ocak 2024

Lisans

Lisans